Biotech, high tech to drive IPO offering pick up: Deloitte

  • By Crystal Hsu / Staff reporter

The number of initial public offerings (IPO) would pick up this year, driven by high tech and biotechnology firms seeking to grow and upgrade by taking advantage of the local capital market, Deloitte & Touche Taiwan said yesterday.

Deloitte Taiwan’s guarded optimistic outlook came after IPOs last year totaled 45 and together raised a 10-year high of NT$37.9 billion (US$1.213 billion), at odds with a global slowdown amid lingering economic uncertainty and geopolitical tensions.

“The local IPO market has a good chance of flourishing this year, helped by an economic recovery as well as regulatory easing and promotion of the Taiwan Innovation Board, a new platform…



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.